MedTrace Logo

Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population

NCT01191112 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2015-03-03

No results posted yet for this study

Summary

The objective of this study is to determine the safe use and tolerance of a peptide-based formula in children with gastrointestinal dysfunction and/or feeding intolerance.

Conditions

  • Gastrointestinal Diseases
  • Feeding Intolerance

Interventions

OTHER

Peptide based enteral formula

Sole source nutrition as per HCP

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Jennifer Williams, MPH · Abbott Nutrition

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01191112 on ClinicalTrials.gov